HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.

AbstractBACKGROUND:
Inflammation plays an important role in the pathogenesis of Parkinson's disease (PD) through over-activation of microglia, which consequently causes the excessive production of proinflammatory and neurotoxic factors, and impacts surrounding neurons and eventually induces neurodegeneration. Hence, prevention of microglial over-activation has been shown to be a prime target for the development of therapeutic agents for inflammation-mediated neurodegenerative diseases.
METHODS:
For in vitro studies, mesencephalic neuron-glia cultures and reconstituted cultures were used to investigate the molecular mechanism by which FLZ, a squamosamide derivative, mediates anti-inflammatory and neuroprotective effects in both lipopolysaccharide-(LPS)- and 1-methyl-4-phenylpyridinium-(MPP+)-mediated models of PD. For in vivo studies, a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-(MPTP-) induced PD mouse model was used.
RESULTS:
FLZ showed potent efficacy in protecting dopaminergic (DA) neurons against LPS-induced neurotoxicity, as shown in rat and mouse primary mesencephalic neuronal-glial cultures by DA uptake and tyrosine hydroxylase (TH) immunohistochemical results. The neuroprotective effect of FLZ was attributed to a reduction in LPS-induced microglial production of proinflammatory factors such as superoxide, tumor necrosis factor-alpha (TNF-alpha), nitric oxide (NO) and prostaglandin E2 (PGE2). Mechanistic studies revealed that the anti-inflammatory properties of FLZ were mediated through inhibition of NADPH oxidase (PHOX), the key microglial superoxide-producing enzyme. A critical role for PHOX in FLZ-elicited neuroprotection was further supported by the findings that 1) FLZ's protective effect was reduced in cultures from PHOX-/- mice, and 2) FLZ inhibited LPS-induced translocation of the cytosolic subunit of p47PHOX to the membrane and thus inhibited the activation of PHOX. The neuroprotective effect of FLZ demonstrated in primary neuronal-glial cultures was further substantiated by an in vivo study, which showed that FLZ significantly protected against MPTP-induced DA neuronal loss, microglial activation and behavioral changes.
CONCLUSION:
Taken together, our results clearly demonstrate that FLZ is effective in protecting against LPS- and MPTP-induced neurotoxicity, and the mechanism of this protection appears to be due, at least in part, to inhibition of PHOX activity and to prevention of microglial activation.
AuthorsDan Zhang, Xiaoming Hu, Sung-Jen Wei, Jie Liu, Huiming Gao, Li Qian, Belinda Wilson, Gengtao Liu, Jau-Shyong Hong
JournalJournal of neuroinflammation (J Neuroinflammation) Vol. 5 Pg. 21 (May 28 2008) ISSN: 1742-2094 [Electronic] England
PMID18507839 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antiparkinson Agents
  • Benzeneacetamides
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • Neuroprotective Agents
  • Phenols
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • squamosamide
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Dinoprostone
  • Dopamine
Topics
  • Animals
  • Antiparkinson Agents (pharmacology, therapeutic use)
  • Benzeneacetamides (chemistry, pharmacology, therapeutic use)
  • Cells, Cultured (drug effects)
  • Dinoprostone (biosynthesis, genetics)
  • Dopamine (metabolism)
  • Female
  • Lipopolysaccharides (toxicity)
  • Male
  • Membrane Glycoproteins (deficiency, genetics)
  • Mesencephalon (cytology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia (drug effects, physiology)
  • NADPH Oxidase 2
  • NADPH Oxidases (antagonists & inhibitors, deficiency, genetics)
  • Nerve Degeneration (prevention & control)
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Parkinsonian Disorders (drug therapy)
  • Phenols (chemistry, pharmacology, therapeutic use)
  • Pregnancy
  • Protein Transport (drug effects)
  • Rats
  • Rats, Inbred F344
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: